CLINICAL AND SUBCLINICAL CHARACTERISTICS AND EMBRYO OUTCOMES USING THE RANDOM-START PROGESTIN-PRIMED OVARIAN STIMULATION PROTOCOL IN INFERTILE WOMEN WITH NORMAL OVARIAN RESERVE

Thế Sơn Trịnh , Ngọc Nhất Nguyễn

Main Article Content

Abstract

Objective: To describe the clinical and ovarian reserve characteristics of infertile women participating in the study and their response to the Random-start Progestin-Primed Ovarian Stimulation (PPOS) protocol in in vitro fertilization (IVF) treatment. Subjects and Methods: This was a retrospective descriptive study conducted at the Military Institute of Clinical Embryology and Histology - Vietnam Military Medical University and Viet Bi Fertility and Andrology Hospital from January 2024 to June 2025. Inclusion criteria included infertile couples undergoing IVF treatment, a freeze-all strategy, and normal ovarian reserve. Serum AMH, antral follicle count (AFC), and hormone levels on the day of stimulation initiation (FSH, LH, estradiol, progesterone, βhCG) were measured. The Random-start PPOS protocol involved using exogenous gonadotropin and progestin at any point in the menstrual cycle, followed by GnRH agonist for oocyte maturation. Intracytoplasmic sperm injection (ICSI) was performed, and embryos were cultured to the blastocyst stage for quality assessment. Results: The mean age of the study group was 33.46 ± 5.76 years, with a mean serum AMH of 3.89 ± 2.35 ng/mL and a mean AFC of 12.50 ± 4.33 follicles. The protocol yielded a mean of 7.60 ± 5.73 mature oocytes (MII), 5.68 ± 4.59 cleavage-stage embryos, and 3.64 ± 3.06 blastocysts. Conclusion: The Random-start PPOS protocol was found to be effective and safe for infertile women with normal ovarian reserve. This protocol not only yielded comparable oocyte and embryo outcomes to current common protocols.

Article Details

References

Venetis C.A., Storr A., Chua S.J. và cộng sự. (2023). What is the optimal GnRH antagonist protocol for ovarian stimulation during ART treatment? A systematic review and network meta-analysis. Hum Reprod Update, 29(3), 307–326.
2. Kadoura S., Alhalabi M., và Nattouf A.H. (2022). Conventional GnRH antagonist protocols versus long GnRH agonist protocol in IVF/ICSI cycles of polycystic ovary syndrome women: a systematic review and meta-analysis. Sci Rep, 12(1), 4456.
3. Pereira N., Voskuilen-Gonzalez A., Hancock K. và cộng sự. (2017). Random-start ovarian stimulation in women desiring elective cryopreservation of oocytes. Reprod Biomed Online, 35(4), 400–406.
4. Wang Y., Chen Q., Wang N. và cộng sự. (2016). Controlled Ovarian Stimulation Using Medroxyprogesterone Acetate and hMG in Patients With Polycystic Ovary Syndrome Treated for IVF: A Double-Blind Randomized Crossover Clinical Trial. Medicine (Baltimore), 95(9), e2939.
5. Ye H., Shi L., Quan X. và cộng sự. (2024). Cumulative live birth rate of in vitro fertilization cycle via progestin-primed ovarian stimulation versus gonadotropin-releasing hormone antagonist protocol in infertile women with normal ovarian reserve: an open-label, randomized controlled trial. Hum Fertil Camb Engl, 27(1), 2316005.
6. Huang H., Itaya Y., Samejima K. và cộng sự. (2022). Usefulness of random-start progestin-primed ovarian stimulation for fertility preservation. J Ovarian Res, 15.
7. Zhou R., Dong M., Huang L. và cộng sự. (2023). Comparison of cumulative live birth rates between progestin-primed ovarian stimulation protocol and gonadotropin-releasing hormone antagonist protocol in different populations. Front Endocrinol, 14, 1117513.
8. Xu S., Wang X., Zhang Y. và cộng sự. (2023). Comparison the effects of progestin-primed ovarian stimulation (PPOS) protocol and GnRH-a long protocol in patients with normal ovarian reserve function. Gynecol Endocrinol Off J Int Soc Gynecol Endocrinol, 39(1), 2217263.